Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
about
Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@en
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@nl
type
label
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@en
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@nl
prefLabel
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@en
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Risk factors for rituximab-ind ...... ients with malignant lymphoma.
@en
P2093
Chang-Ho Kim
Jae-Yong Park
Jaehee Lee
Jaekwang Lim
Keum-Ju Choi
Kyung-Min Shin
Seung-Ick Cha
Seung-Soo Yoo
Shin-Yup Lee
P2860
P356
10.1159/000345211
P577
2012-12-07T00:00:00Z